Lora L Arnold Selected Research

Lora L Arnold Research Topics

Disease

29	Neoplasms (Cancer) 07/2022 - 02/2006
19	Hyperplasia 01/2021 - 09/2002
10	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 02/2006
9	Carcinogenesis 01/2021 - 03/2007
6	Necrosis 05/2014 - 03/2007
5	Hemangiosarcoma (Angiosarcoma) 10/2013 - 12/2007
5	Myopia 3 07/2012 - 09/2002
3	Carcinoma (Carcinomatosis) 01/2018 - 02/2006
3	Hyperlipidemias (Hyperlipidemia) 12/2011 - 12/2007
2	Cryptorchidism (Undescended Testes) 04/2022 - 01/2021
2	Calculi (Calculus) 11/2020 - 02/2010
2	Body Weight (Weight, Body) 03/2018 - 07/2012
2	Hemangioma (Angioma) 10/2013 - 07/2013
2	Type 2 Diabetes Mellitus (MODY) 12/2011 - 05/2009
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Urinary Calculi (Urinary Calculus) 11/2020
1	Starvation 03/2018
1	Dehydration (Water Stress) 03/2018
1	Papilloma (Papillomatosis) 05/2014
1	Lung Neoplasms (Lung Cancer) 01/2014
1	Leukemia 08/2013
1	Acute Promyelocytic Leukemia 08/2013
1	Heavy Metal Poisoning 09/2012
1	Ovarian Neoplasms (Ovarian Cancer) 01/2012
1	Urolithiasis 04/2009

Drug/Important Bio-Agent (IBA)

14	ArsenicIBA 11/2016 - 02/2006
8	Drinking WaterIBA 01/2020 - 01/2007
8	CarcinogensIBA 07/2014 - 02/2006
8	arseniteIBA 07/2014 - 07/2008
5	Bromodeoxyuridine (BrdU)IBA 11/2020 - 09/2002
5	Arsenicals (Arsenic Compounds)IBA 11/2016 - 09/2002
5	PPAR gammaIBA 12/2011 - 12/2007
4	Nicotine FDA Link 01/2021 - 01/2014
4	arsenic acid (arsenate)IBA 07/2014 - 07/2008
4	Pharmaceutical PreparationsIBA 10/2013 - 03/2007
3	Diuron (DCMU)IBA 05/2014 - 12/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 02/2006
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2011 - 12/2007
3	muraglitazarIBA 02/2010 - 03/2007
3	PPAR alphaIBA 02/2010 - 03/2007
2	tert-Butyl Alcohol (tert-Butanol)IBA 07/2022 - 03/2019
2	acetovanillone (apocynin)IBA 01/2021 - 06/2009
2	dimethylarsinous acidIBA 10/2013 - 06/2009
2	monomethylarsonous acidIBA 10/2013 - 09/2002
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2013 - 07/2013
2	von Willebrand FactorIBA 10/2013 - 07/2013
2	AcidsIBA 09/2012 - 06/2011
2	Unithiol (DMPS)IBA 09/2012 - 09/2002
2	Troglitazone (Rezulin)FDA Link 09/2011 - 05/2009
2	Pioglitazone (Actos)FDA Link 09/2011 - 02/2010
2	sodium arsenite (sodium metaarsenite)IBA 04/2010 - 09/2002
1	Dibutyl Phthalate (Butyl Phthalate)IBA 04/2022
1	Messenger RNA (mRNA)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	CholesterolIBA 01/2021
1	pyroxasulfoneIBA 11/2020
1	CotinineIBA 01/2020
1	polihexanideIBA 03/2018
1	Disinfectants (Biocides)IBA 03/2018
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2018
1	ButylhydroxybutylnitrosamineIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 11/2016
1	Biological ProductsIBA 11/2016
1	HerbicidesIBA 05/2014
1	Urea (Carbamide)FDA LinkGeneric 05/2014
1	AminesIBA 01/2014
1	SmokeIBA 01/2014
1	Arsenic Trioxide (Trisenox)FDA Link 08/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2013
1	AntigensIBA 07/2013
1	Chelating AgentsIBA 09/2012
1	menthoneIBA 07/2012
1	piperitoneIBA 07/2012
1	menthofuranIBA 07/2012
1	BromidesIBA 07/2012
1	piperitenoneIBA 07/2012
1	pulegone (isopulegone)IBA 07/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2012
1	methacrylic acidIBA 01/2012
1	MicellesIBA 01/2012
1	InsecticidesIBA 06/2011
1	Pyrethrins (Pyrethroids)FDA Link 06/2011
1	transfluthrinIBA 06/2011
1	MethyltransferasesIBA 07/2010
1	CalciumIBA 02/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2009
1	Gefitinib (Iressa)FDA Link 06/2009
1	Phosphotransferases (Kinase)IBA 06/2009
1	Cell Surface ReceptorsIBA 06/2009
1	tyrosine receptor (receptor, tyrosine)IBA 06/2009
1	Staphylococcal Protein A (Protein A)IBA 04/2009
1	Citric Acid (Citrate)FDA LinkGeneric 04/2009
1	IonsIBA 04/2009

Therapy/Procedure

2	Orchiopexy 04/2022 - 01/2021
2	Aftercare (After-Treatment) 08/2013 - 12/2008
1	RNAi Therapeutics 01/2021
1	Therapeutics 01/2021
1	Oral Administration 07/2012
1	Chemoprevention 03/2011